Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Dana-Farber Cancer Institute
Age
18–50
Sex
FEMALE
Healthy volunteers
Accepted
You may be eligible if
History of lobular carcinoma in situ, atypical ductal/lobular hyperplasia on prior breast biopsy or lifetime risk of breast cancer of at least 20% based on any risk model, or personal history of BRCA1 or 2 mutation
Physically able to exercise and physician consent to start an exercise program
Sedentary activity pattern
Premenopausal
English speaking and able to read English
You may not be if
History of invasive breast cancer or ductal carcinoma in situ
Absolute contraindications to maximal exercise testing as recommended by the American Thoracic Society
Any condition which in the investigator's opinion makes the subject unsuitable for study participation
Participating in another clinical study with competing study outcomes
Pregnant or breastfeeding
Unable to comply with protocol and/or not available for follow-ups
Type II Diabetes
Allergic to local anesthetics
History of bilateral or unilateral mastectomy
Clareo Health | RPFNA Assessment of Exercise Effect in Breast Cancer